Dozens of prescription and over-the-counter medications can cause noticeable weight loss even when they are not prescribed for that purpose. Stimulants, certain antidepressants, seizure medications, diabetes drugs, chemotherapy agents, and even antifungal pills all have well-documented track records of trimming pounds as an unintended consequence. The mechanisms vary widely, from appetite suppression and altered taste to blocking fat absorption and changing the way your body handles blood sugar. Understanding which drugs carry this side effect, and why, helps you and your doctor distinguish welcome weight change from something that needs attention.
Stimulants and ADHD Medications
If you have ever known someone who started a stimulant medication for attention-deficit/hyperactivity disorder and dropped weight quickly, you saw one of the most predictable drug-related weight changes in medicine. Stimulant medications like amphetamine-based drugs and methylphenidate suppress appetite through their action on dopamine and norepinephrine signaling in the brain. They have long been recognized as effective at reducing hedonic appetite, the kind of eating driven by pleasure and reward rather than genuine hunger.1PubMed Central. Stimulants for the Control of Hedonic Appetite
The appetite-killing effect is not just a short-term blip. Stimulants interact with hormonal signals that regulate hunger, including ghrelin (which tells your brain you are hungry) and leptin (which tells your brain you are full). Over time, these drugs can alter the body’s ability to recognize and respond to energy deficits, which is why weight loss on stimulants can be persistent and sometimes excessive.2PubMed. Nutritional and metabolic alterations arising from stimulant use: A targeted review of an emerging field Children on ADHD stimulants often experience growth concerns, and adults may find they simply forget to eat. If you are losing more weight than expected on a stimulant, your prescriber may adjust your dose or switch to a non-stimulant alternative.
Bupropion and the Antidepressant Exception
Most antidepressants are associated with weight gain, not loss. SSRIs like fluoxetine and sertraline, along with older tricyclic antidepressants, tend to add pounds over time. Bupropion is the major exception. Because it works through norepinephrine and dopamine reuptake inhibition rather than serotonin, the common side effects linked to serotonin-based antidepressants, including weight gain, sexual dysfunction, and sedation, do not typically occur with bupropion therapy.3PubMed Central. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor
In practice, many people on bupropion lose a modest amount of weight, and some lose quite a bit. The drug is one half of the combination product Contrave (bupropion plus naltrexone), which is approved specifically for weight management. If you are being treated for depression and weight gain from a previous antidepressant is a concern, bupropion is often the first alternative your doctor considers. It does come with its own side effects, including insomnia and a slightly elevated seizure risk at high doses, so it is not universally suitable.
Topiramate and Other Anticonvulsants
Topiramate was developed to treat epilepsy and later approved for migraine prevention, but its ability to cause weight loss has become arguably its most talked-about side effect. The drug appears to reduce calorie intake, decrease fat accumulation, lower triglyceride and cholesterol levels, and dampen the reward pathways associated with eating. Multiple clinical studies have shown it to be effective at reducing body weight across various dosages and sustaining that loss over time.4PubMed Central. Topiramate (Topamax): Evolving Role in Weight Reduction Management: A Narrative Review
Like bupropion, topiramate has found a second life in obesity treatment. It is paired with phentermine in the combination drug Qsymia. But even when prescribed purely for seizures or migraines, weight loss is common enough that clinicians often mention it before you start. The cognitive side effects can be bothersome: many people report word-finding difficulty, mental fogginess, and tingling in their hands and feet. Some neurologists informally call it “dopamax” because patients describe feeling spacey. Zonisamide, another anticonvulsant, has a similar though less dramatic weight-loss profile.
Diabetes Medications That Shed Pounds
Several classes of diabetes drugs cause weight loss through completely different mechanisms, and the scale of that loss ranges from modest to dramatic depending on the medication.
Metformin
Metformin has been a first-line treatment for type 2 diabetes for decades. Weight loss on metformin is usually moderate, typically a few kilograms, but research has clarified why it happens. When taken orally, metformin increases levels of a hormone called GDF15, which suppresses appetite and reduces food intake. In studies, the therapeutic benefits of metformin on appetite, body weight, and insulin levels depended on this GDF15 pathway.5PubMed. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss Gastrointestinal side effects like nausea and diarrhea also contribute to reduced food intake in some people, especially when they first start the drug.
SGLT2 Inhibitors
Drugs like empagliflozin, dapagliflozin, and canagliflozin work in a fundamentally different way. They cause the kidneys to excrete excess glucose into urine, which means you are literally peeing out calories. In one study tracking patients over 90 weeks, the calorie loss through this urinary glucose excretion averaged about 206 calories per day. You might expect dramatic weight loss from that deficit, but the body partially compensates: patients increased their calorie intake by roughly 13%, and the average weight loss came out to about 3.2 kilograms rather than the 11 kilograms the calorie math predicted.6PubMed Central. Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition The body fights back against calorie deficits, which is a recurring theme in weight pharmacology.
GLP-1 Receptor Agonists
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have become the most discussed weight-loss drugs in a generation, but they were originally developed for diabetes. Older GLP-1 drugs produced average weight reductions of roughly 3 to 5% of initial body weight over 6 to 12 months of treatment. The newer agents reach a different scale entirely: semaglutide can produce losses of up to about 15% of total body weight, and tirzepatide has shown results exceeding 20%.7PubMed Central. Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight loss These drugs slow stomach emptying, reduce appetite at the brain level, and alter the hormonal cascade that follows meals. For many patients prescribed them for blood sugar control, the weight loss was initially a “side effect” that reshaped the entire conversation around obesity treatment.
Drugs That Change How Food Tastes or Gets Absorbed
Some medications cause weight loss not by suppressing appetite directly but by making food unappealing or by blocking its absorption.
Terbinafine, a common antifungal used for nail infections, is a surprising culprit. It can cause severe taste distortion, known as dysgeusia, where everything takes on a metallic flavor and sweet foods become repulsive. In one reported case, a 72-year-old woman developed profound taste changes shortly after starting oral terbinafine, leading to food aversion and progressive unintentional weight loss.8PubMed Central. Severe dysgeusia and weight loss associated with terbinafine use: A case report The taste changes can persist for weeks or even months after stopping the drug. Other medications known to distort taste include certain antibiotics, ACE inhibitors used for blood pressure, and some chemotherapy agents.
Orlistat (sold as Xenical by prescription and Alli over the counter) takes a different approach. It inhibits lipase enzymes in the gut, preventing about a third of the fat you eat from being absorbed.9PubMed. Orlistat: selective inhibition of caloric absorption can affect long-term body weight That unabsorbed fat passes through your digestive tract and exits, sometimes urgently and unpleasantly. The gastrointestinal side effects, including oily stools, flatulence, and fecal urgency, are themselves a behavioral deterrent against eating fatty foods. In trials lasting up to two years, orlistat produced more weight loss than diet alone and helped maintain the weight that had been lost.10PubMed Central. Orlistat, a new lipase inhibitor for the management of obesity
Chemotherapy and Cancer Treatments
Weight loss during cancer treatment is so common that clinicians monitor it as a key indicator of how a patient is tolerating therapy. Multiple mechanisms drive this. Chemotherapy agents like methotrexate directly suppress food and water intake and cause losses of both lean and fat tissue.11PubMed. Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration Nausea, mouth sores, taste changes, and generalized inflammation all stack on top of each other to make eating feel impossible.
Targeted cancer therapies carry similar risks. Drugs that block blood vessel growth in tumors, known as VEGFR tyrosine kinase inhibitors, frequently cause anorexia as a complication, which contributes to malnutrition and body weight loss in affected patients.12PubMed Central. The Incidence and Management of Cancer-Related Anorexia During Treatment with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors Unlike the weight loss from diabetes drugs or stimulants, cancer-treatment weight loss often involves significant muscle wasting and can progress to cachexia, a dangerous condition where the body breaks down muscle tissue even with adequate nutrition. Managing calories and protein intake during cancer treatment is considered a clinical priority, not an afterthought.
Nicotine and Smoking
Nicotine is not a prescription drug in most contexts, but nicotine-containing products like patches, gums, and prescription cessation aids are commonly used, and the weight effects are relevant to anyone quitting smoking. Nicotine acts as an appetite suppressant, reducing food intake and increasing energy expenditure, which is why smokers tend to weigh less than nonsmokers on average. When people quit smoking, they typically gain about 4 to 5 kilograms within the first year, driven by both higher calorie intake and a drop in metabolic rate.13PubMed Central. Cigarette smoking, nicotine, and body weight
This weight dynamic is one of the most commonly cited reasons people hesitate to quit smoking, and it plays a role in relapse. Some clinicians pair smoking cessation with bupropion partly for this reason, since bupropion treats both nicotine addiction and tends to prevent weight gain. Understanding this connection helps explain why some people who start nicotine replacement therapy during a quit attempt still gain weight: the replacement delivers enough nicotine to ease cravings but not always enough to maintain the metabolic boost that full-strength smoking provided.
The Muscle Loss Problem
Not all weight loss is created equal, and drugs that cause rapid or substantial weight reduction often take muscle along with fat. This has become a prominent concern with GLP-1 receptor agonists, where the dramatic results have drawn attention to what exactly is being lost. In trials of incretin-based drugs, fat mass decreased by roughly 19 to 34%, but fat-free mass, which is mostly muscle, dropped by about 7 to 11%. That means roughly a third of total weight lost was lean tissue rather than fat.14PubMed Central. Defining Healthy Weight Loss and Target Weight in the Era of Highly Effective Treatment of Patients With Obesity
Skeletal muscle loss is a concern beyond cosmetics. Muscle is metabolically active tissue that supports bone health, glucose regulation, mobility, and long-term survival, especially as people age. The rapid increase in GLP-1 receptor agonist use has prompted researchers to highlight that these drugs cause loss of skeletal muscle in addition to the desired reduction in fat.15PubMed Central. Advantages of Skeletal Muscle Preservation in Settings of Weight Loss The practical advice from most experts is to maintain adequate protein intake and engage in resistance exercise while on any medication that causes significant weight loss. This applies to stimulants, topiramate, and diabetes drugs alike.
When Weight Loss Changes Your Other Medications
An underappreciated consequence of drug-induced weight loss is that it can throw off the dosing of other medications you are already taking. Thyroid replacement therapy is a clear example. One case report documented a patient on levothyroxine for an underactive thyroid who lost substantial weight on semaglutide. The weight loss meant her levothyroxine dose was now too high for her smaller body, pushing her into a state of over-suppressed thyroid function with symptoms of hyperthyroidism. Her dose had to be reduced to match her new weight.16PubMed Central. Semaglutide therapy and iatrogenic thyrotoxicosis
This kind of dose mismatch can happen with many weight-sensitive medications, including blood thinners, blood pressure drugs, and insulin. If you lose a significant amount of weight on any medication, scheduled follow-ups to re-evaluate your full prescription list become important. The mechanism behind the thyroid case is not fully understood but may involve increased absorption of the medication or simply the body needing less drug at a lower weight. Either way, the clinical lesson is the same: weight loss from one drug can create problems with another if nobody is paying attention.
Off-Label Prescribing for Weight Loss
The boundary between “drugs that cause weight loss as a side effect” and “drugs prescribed for weight loss” is blurry by design. Physicians in the United States have a long history of turning to off-label drug use to help patients with excess weight. Phentermine, a stimulant originally approved for short-term use only, has been prescribed for long-term weight management since its initial approval in 1959 and remains the most commonly used drug for treating obesity in the U.S.17PubMed Central. Off-label drugs for weight management
Topiramate, metformin, and bupropion are all frequently prescribed off-label for weight reduction when their approved indications overlap with a patient’s other conditions. A neurologist who prescribes topiramate for migraines in someone who also wants to lose weight is technically staying on-label, but the choice of topiramate over a weight-neutral migraine drug is deliberate. This kind of strategic prescribing is routine. It also means that if you ask your doctor whether any of your current medications might be contributing to weight changes, the answer may be more nuanced than a simple yes or no. A drug’s weight effect can simultaneously be an unintended side effect for one patient and the primary reason another patient is taking it.
Less Obvious Culprits
Beyond the major categories above, weight loss crops up as a side effect in some surprising places. Certain antibiotics cause enough gastrointestinal distress to reduce calorie intake for weeks. Decongestants containing pseudoephedrine have mild stimulant properties that can suppress appetite. Some cardiac medications, particularly digoxin at higher levels, cause nausea that limits food intake. Levodopa, used for Parkinson’s disease, is associated with nausea and reduced appetite, especially early in treatment. And thyroid hormone replacement itself, when dosed slightly above what is needed, increases metabolic rate and causes unintended weight loss, as the semaglutide-thyroid interaction described above illustrates.
The practical point is that unintentional weight loss on any medication deserves a conversation with your prescriber. A few pounds are usually nothing to worry about, but progressive weight loss, especially if accompanied by muscle weakness, fatigue, or loss of appetite, can signal that a dose needs adjusting or a medication needs changing. Keeping a rough log of your weight when you start a new drug gives both you and your doctor a baseline to work from. And if the weight loss is welcome, resistance exercise and protein intake remain the best insurance against losing the wrong kind of tissue along with the fat.